Efficacy of Ultrasound-guided Transverse Carpal Ligament Release for Carpal Tunnel Syndrome - Trial NCT06251674
Access comprehensive clinical trial information for NCT06251674 through Pure Global AI's free database. This phase not specified trial is sponsored by Peking University People's Hospital and is currently Completed. The study focuses on Carpal Tunnel Syndrome. Target enrollment is 60 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Peking University People's Hospital
Timeline & Enrollment
N/A
Jan 01, 2020
Dec 30, 2023
Primary Outcome
visual analogue scale(VAS) scores
Summary
Carpal tunnel syndrome (CTS) is one of the most common peripheral nerve entrapment
 neuropathies, and it is characterized by pain, numbness, tingling, and weakness in the
 regions innervated by the median nerve (MN). CTS is believed to result from compression of
 the MN as it passes through the narrowed carpal tunnel with regard to gradual ischemia and
 fibrosis.Ultrasound-guided needle release of transverse carpal ligament(TCL) is an effective
 method to decompress the carpal.There are two main approaches to perform the release,
 short-axis or long-axis. However, there is no consensus about the optimal strategy.Thus, this
 study aimed to compare the efficacy of these two approaches for patients with
 mild-to-moderate CTS.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06251674
Non-Device Trial